Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
- Status
- COMPLETED
- Phase
- N/A
Isatuximab in Type I Cryoglobulinemia
- Status
- UNKNOWN
- Phase
- PHASE2
Descartes-25 in Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Stem Cell Translpantation in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma (FUMANBA-1)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
- Status
- COMPLETED
- Phase
- NA
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
- Status
- RECRUITING
- Phase
- NA
Marizomib Central Nervous System (CNS)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Biology and Genetics of Smouldering Myeloma
- Status
- UNKNOWN
- Phase
- N/A
Feasibility Study of an ePRO Monitoring for Patients With Multiple Myeloma and Development of Item Lists
- Status
- COMPLETED
- Phase
- N/A